Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
The American Journal of Managed Care
|
August 30, 2012
Measuring migraine-related quality of care across 10 health plans
Valerie P Pracilio, Stephen Silberstein, Joseph Couto, et al.
Cephalalgia : an International Journal of Headache
|
May 2, 2019
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults
Marie Deen, Daniele Martinelli, Judith Pijpers, et al.
Annals of Neurology
|
December 7, 2007
Cutaneous allodynia in the migraine population
Richard B Lipton, Marcelo E Bigal, Sait Ashina, et al.
Headache
|
May 6, 2015
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks
Stewart J Tepper, Roger K Cady, Stephen Silberstein, et al.
The Lancet. Neurology
|
May 3, 2017
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper, Messoud Ashina, Uwe Reuter, et al.
Neurology and Therapy
|
August 5, 2023
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
Andrew M Blumenfeld, Richard B Lipton, Stephen Silberstein, et al.
The Lancet. Neurology
|
June 9, 2019
Pathophysiology, prevention, and treatment of medication overuse headache
Hans-Christoph Diener, David Dodick, Stefan Evers, et al.
The Journal of Headache and Pain
|
October 7, 2020
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study
Stephen Silberstein, Merle Diamond, Nada A Hindiyeh, et al.
Arquivos De Neuro-Psiquiatria
|
April 9, 2008
Episodic migraine associated with postural orthostatic tachycardia syndrome and vasovagal syncope: migraine triggers neuromediated syncope
Elcio Juliato Piovesan, Claudia Ferreira Sobreira, Rosana Herminia Scola, et al.
Cephalalgia : an International Journal of Headache
|
October 27, 2010
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study
Richard B Lipton, Stephen Silberstein, David Dodick, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
The American Journal of Managed Care
|
August 30, 2012
Measuring migraine-related quality of care across 10 health plans
Valerie P Pracilio, Stephen Silberstein, Joseph Couto, et al.
Cephalalgia : an International Journal of Headache
|
May 2, 2019
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults
Marie Deen, Daniele Martinelli, Judith Pijpers, et al.
Annals of Neurology
|
December 7, 2007
Cutaneous allodynia in the migraine population
Richard B Lipton, Marcelo E Bigal, Sait Ashina, et al.
Headache
|
May 6, 2015
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks
Stewart J Tepper, Roger K Cady, Stephen Silberstein, et al.
The Lancet. Neurology
|
May 3, 2017
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper, Messoud Ashina, Uwe Reuter, et al.
Neurology and Therapy
|
August 5, 2023
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
Andrew M Blumenfeld, Richard B Lipton, Stephen Silberstein, et al.
The Lancet. Neurology
|
June 9, 2019
Pathophysiology, prevention, and treatment of medication overuse headache
Hans-Christoph Diener, David Dodick, Stefan Evers, et al.
The Journal of Headache and Pain
|
October 7, 2020
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study
Stephen Silberstein, Merle Diamond, Nada A Hindiyeh, et al.
Arquivos De Neuro-Psiquiatria
|
April 9, 2008
Episodic migraine associated with postural orthostatic tachycardia syndrome and vasovagal syncope: migraine triggers neuromediated syncope
Elcio Juliato Piovesan, Claudia Ferreira Sobreira, Rosana Herminia Scola, et al.
Cephalalgia : an International Journal of Headache
|
October 27, 2010
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study
Richard B Lipton, Stephen Silberstein, David Dodick, et al.
Page
of 9